Consolidated Portfolio Review Corp Takes Position in Aflac Incorporated (NYSE:AFL)

Consolidated Portfolio Review Corp purchased a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 3,388 shares of the financial services provider's stock, valued at approximately $377,000.

Several other hedge funds have also recently modified their holdings of the stock. Whipplewood Advisors LLC acquired a new stake in shares of Aflac in the 4th quarter worth $26,000. Garde Capital Inc. purchased a new position in Aflac during the first quarter worth about $36,000. BankPlus Trust Department acquired a new stake in Aflac in the fourth quarter valued at about $34,000. Curio Wealth LLC purchased a new stake in Aflac in the 4th quarter valued at approximately $36,000. Finally, Capital A Wealth Management LLC acquired a new position in Aflac during the 4th quarter worth approximately $38,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Raymond James Financial reduced their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Morgan Stanley upped their price target on shares of Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Barclays raised their price objective on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research note on Thursday, May 1st. Finally, Wells Fargo & Company upped their target price on shares of Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $104.93.

Aflac Stock Down 0.6%

Shares of NYSE AFL opened at $104.18 on Wednesday. Aflac Incorporated has a 12-month low of $88.00 and a 12-month high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. The firm's 50-day moving average is $104.76 and its two-hundred day moving average is $105.21. The company has a market capitalization of $56.33 billion, a PE ratio of 16.28, a price-to-earnings-growth ratio of 3.25 and a beta of 0.82.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. Aflac's revenue for the quarter was down 37.5% on a year-over-year basis. During the same quarter last year, the company posted $1.66 earnings per share. Equities analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were issued a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a dividend yield of 2.23%. The ex-dividend date was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is 36.25%.

Insider Activity

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director now directly owns 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director now owns 70,992 shares of the company's stock, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 40,750 shares of company stock valued at $4,304,295 over the last quarter. Company insiders own 0.80% of the company's stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.